In situ carcinoma of the conjunctiva: surgical excision associated with cryotherapy
Authors Crim N, Forniés-Paz ME, Monti R, Espósito E, Maccio JP, Urrets-Zavalía JA
Received 30 June 2013
Accepted for publication 7 August 2013
Published 19 September 2013 Volume 2013:7 Pages 1889—1893
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Nicolás Crim, María Elena Forniés-Paz, Rodolfo Monti, Evangelina Espósito, Juan Pablo Maccio, Julio A Urrets-Zavalía
Department of Ophthalmology, University Clinic Reina Fabiola, Universidad Católica de Córdoba, Argentina
Background: Although frequently underdiagnosed, squamous cell carcinoma is the most commonly observed malignancy of the conjunctiva. Multiple different treatments have been proposed to date. The purpose of this paper is to report our experience in the treatment of In situ carcinoma of the conjunctiva by surgical excision associated with cryotherapy.
Methods: Four eyes in four consecutive patients (two men and two women) of average age 53.2 (range 39–71) years at the time of diagnosis of ocular surface squamous neoplasia were treated by simple surgical excision and cryotherapy of the resulting surgical bed margins. In all cases, the diagnosis of in situ carcinoma was confirmed histopathologically.
Results: On histopathology, the edges of the surgical specimens were free of malignant cells in three of four patients. All patients showed excellent evolution without recurrence. Mean follow-up was 6.5 (range 2–14) years.
Conclusion: In situ carcinoma of the conjunctiva may be simply and successfully treated with surgical excision and cryotherapy.
Keywords: conjunctival squamous cell carcinoma, surgical excision, cryotherapy
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]